To view the PDF file, sign up for a MySharenet subscription.

DIS-CHEM PHARMACIES LIMITED - Directorate change to board committees

Release Date: 20/09/2022 17:00
Code(s): DCP     PDF:  
Wrap Text
Directorate change to board committees

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or “the Company”)

DIRECTORATE CHANGE TO BOARD COMMITTEES

In compliance with paragraph 3.59(c) of the JSE Limited Listings Requirements, shareholders are advised
that Mr Katlego Kobue in his capacity as a non-executive director (“NED”), has been appointed to the Dis-
Chem Social and Ethics Sub-Committee (“SEC”). In addition Ms Alupheli Sithebe in her capacity as a NED,
also an existing member of the SEC, has been appointed as the Chairperson of the SEC, replacing Ms
Anuschka Coovadia who has stepped down as Chair but will remain a member of the SEC.
Mr Johannes Mthimunye in his capacity as a NED, an existing member of the Remuneration Sub-Committee,
has been appointed as the Chairperson of this committee to replace Mr Mark Bowman who recently resigned
from the Board.
These appointments are effective 19 September 2022.

By order of the Board
Nikki Lumley
Company Secretary

20 September 2022
Sponsor
The Standard Bank of South Africa Limited

Date: 20-09-2022 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.